Prysmian’s Atkore Deal Offers $95 a Share, Subject to Closing
Prysmian agreed $95 cash per Atkore share. Its October 7 statement targeted October 19 closing with conditions; completion was not verified in this report.
United States Capital Markets News
Capital-markets reporting focused on the United States.
IRS ETF Ruling: When a Planned Portfolio Swap Becomes Taxable
An IRS ruling treats a specified ETF contribution-and-redemption plan as a taxable exchange. It does not declare every ETF conversion or holding taxable.
Strive Prices $630 Million SATS Offering: Net Proceeds and Dividend Terms
Strive priced 7 million new SATS preferred shares at $90. Its prospectus estimates $608.15 million net proceeds and makes dividend payments conditional.
Proofpoint Agrees to Buy Varonis for $6.3 Billion
The proposed $6.3 billion acquisition offers $49.75 a Varonis share in cash if completed. A first-half 2027 closing remains conditional.
Bowman Announces Dymaptic Acquisition to Add Geospatial AI
Bowman announced its acquisition of Dymaptic on October 16. The release describes mapping-software capabilities but does not disclose the purchase price.
Travelers Q3 EPS Rises to $9.04, Outpacing Profit Growth
Travelers’ Q3 diluted EPS rose 10% to $9.04, while net income rose a rounded 2%. Share repurchases benefited per-share results; core earnings are non-GAAP.
Truist Q3 EPS: $0.56 Reported, $1.16 Adjusted
A securities-sale loss and RAC loan-sale adjustments explain the gap between Truist’s $0.56 reported diluted EPS and $1.16 non-GAAP adjusted EPS.
Citizens Q3 Profit Rises 29%; Common Dividend Increases to 52 Cents
Citizens reported $636 million in quarterly net income, but $599 million was available to common shareholders. Its higher dividend has an October 30 record date.
State Street Q3 Revenue Grows 13% Year on Year but Slips from Q2
State Street reported $4.004 billion Q3 revenue, up 13% year on year but down 1% from Q2. GAAP diluted earnings were $3.69 a share.
Marsh Q3 Revenue Rises 8%, While Underlying Growth Is 5%
Marsh reported $6.863 billion Q3 revenue and $1.69 GAAP EPS. Its 5% underlying growth and $2.03 adjusted EPS use different measurement bases.
ONEOK Keeps Quarterly Dividend at $1.07; November Dates Confirmed
ONEOK declared an unchanged $1.07 quarterly dividend. The listed ex-date is November 2; payment is scheduled for November 16, not already completed.
City Therapeutics Prices $200 Million IPO at $18
City’s October 15 pricing implies about $200 million gross and an estimated $181.5 million net. October 19 is the conditional closing date, not verified completion.